Welcome to Scholar Publishing Group

International Journal of Health and Pharmaceutical Medicine, 2022, 3(2); doi: 10.38007/IJHPM.2022.030205.

Interference with TRIM26 Expression on Proliferation of Glioma Cells

Author(s)

Rashar Almajed

Corresponding Author:
Rashar Almajed
Affiliation(s)

American University in the Emirates, UAE

Abstract

Colloid tumor, as the most common malignant tumor in the brain, seriously endangers human life and health. TRIM 26 expression is closely related to the rapid growth and cell metastasis of most cancer cells. This article mainly studies the effect of interference with TRIM 26 expression on the proliferation of colloid tumor cells. Randomly selected 60 cases of colloid tumor specimens and the brain tissue of 10 cases of brain trauma patients as a normal control group. First, cell culture is performed to observe the growth status of the cells. Subsequently, the SiRNA interference technique was used to interfere with the expression of TRIM 26 on the liver cancer cell lines HepG 2 and Bel-720. The cells were collected for TRIM 26 protein westernBlot and fluorescence quantitative PCR to verify the knockout effect, and the cell proliferation, clone formation, transfer, and invasion experiments were performed. Experimental data showed that among 60 glioma patients, TRIM26 protein samples were positive in 46 cases, and 10 normal brain tissue samples were all negative.The performance of TRIM26 glioma was compared with the performance in normal brain tissue. The difference was significant and statistically significant (p<0.01). The results show that TRIM 26 can reduce the protein level of PBX1 through the correlation of time gradient and concentration gradient. TRIM 26 can reduce the mRNA level of RNF6, the downstream target gene of PBX1, without affecting the mRNA level of PBX1.

Keywords

TRIM26, Glioma Cells, Cell Proliferation, Cell Migration

Cite This Paper

Rashar Almajed. Interference with TRIM26 Expression on Proliferation of Glioma Cells. International Journal of Health and Pharmaceutical Medicine (2022), Vol. 3, Issue 2: 47-58. https://doi.org/10.38007/IJHPM.2022.030205.

References

[1] Eun Hee Kim, Seung U Kim, & Kyeong Sook Choi. (2016). "Rottlerin Sensitizes Glioma Cells to Trail-Induced Apoptosis by Inhibition of Cdc2 and the Subsequent Downregulation of Survivin and Xiap", Oncogene, 24(5), pp.838. https://doi.org/10.1038/sj.onc.1208241

[2] Lijuan Ding, Shudong Wang, Weiyao Wang, Peng Lv, Donghai Zhao, & Feier Chen. (2016). "Tanshinone Iia Affects Autophagy and Apoptosis of Glioma Cells by Inhibiting Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway", Pharmacology, 99(1-2), pp.99. https://doi.org/10.1159/000452340

[3] Zhu, D., Tu, M., Zeng, B., Cai, L., Zheng, W., & Su, Z., et al. (2017). "Up‐Regulation of Mir‐497 Confers Resistance to Temozolomide in Human Glioma Cells by Targeting Mtor/Bcl‐2", Cancer Medicine, 6(2), pp.452-462. https://doi.org/10.1002/cam4.987

[4] Song, H., Zhang, Y., Liu, N., Wan, C., Zhang, D., & Zhao, S., et al. (2016). "Mir-92b Regulates Glioma Cells Proliferation, Migration, Invasion, and Apoptosis Via Pten/Akt Signaling Pathway", Journal of Physiology & Biochemistry, 72(2), pp.201-211. https://doi.org/10.1007/s13105-016-0470-z

[5] Zhi-Qiang, X., Teng-Kun, Y., Ya-Xing, L., Jian-He, Z., & Jian-Jun, G. (2017). "Mir-130b Regulates the Proliferation, Invasion and Apoptosis of Glioma Cells Via Targeting of Cyld", Oncology Reports, 38(1), pp.167-174. https://doi.org/10.3892/or.2017.5651

[6] Tang, J.H., Ma, Z.X., Huang, G.H., Xu, Q.F., Xiang, Y., & Li, N., et al. (2016). "Downregulation of Hif-1a Sensitizes u251 Glioma Cells to the Temozolomide (Tmz) Treatment", Experimental Cell Research, 343(2), pp.148-158. https://doi.org/10.1016/j.yexcr.2016.04.011

[7] Qiao, D., Meyer, K., & Friedl, A. (2016). "Retraction for Qiao et al. Glypican 1 Stimulates s Phase Entry and Dna Replication in Human Glioma Cells and Normal Astrocytes", Molecular & Cellular Biology, 36(15), pp.2105. https://doi.org/10.1128/MCB.00321-16

[8] Mohammed I. Alghamdi, Neutrosophic set with Adaptive Neuro-Fuzzy Inference System for Liver Tumor Segmentation and Classification Model, International Journal of Neutrosophic Science, 2022, Vol. 18, No. 2, pp: 174-185 (Do i: https://doi.org/10.54216/IJNS.180202 ) https://doi.org/10.54216/IJNS.180202

[9] Qin, Q., Yang, X., Zhang, R., Liu, M., and Ma, Y. (2022). An Application of Deep Belief Networks in Early Warning for Cerebrovascular Disease Risk. Journal of Organizational and End User Computing(forthcoming). https://doi.org/10.4018/JOEUC.287574

[10] Antonietti, P., Linder, B., Hehlgans, S., Mildenberger, I.C., & Kogel, D. (2016). "Interference with the Hsf1/Hsp70/Bag3 Pathway Primes Glioma Cells to Matrix Detachment and Bh3 Mimetic-Induced Apoptosis", Molecular Cancer Therapeutics, 16(1), pp.156. https://doi.org/10.1158/1535-7163.MCT-16-0262

[11] Liyang, G., Bing, C., Jinhong, L., Fan, Y., Xuecheng, C., & Zhuangbing, L., et al. (2017). "Wnt/β-Catenin Signaling Pathway Inhibits the Proliferation and Apoptosis of u87 Glioma Cells Via Different Mechanisms", Plos One, 12(8), pp.e0181346. https://doi.org/10.1371/journal.pone.0181346

[12] Ngan Thi Roan, Florentin Smarandache, H-Max Single-Valued Neutrosophic Distance Measure in Medical Diagnosis, International Journal of Neutrosophic Science, 2021, Vol. 15, No. 2, pp: 62-76 (Doi : https://doi.org/10.54216/IJNS.150201)

[13] M. Krichen, S. Mechti, R. Alroobaea, E. Said, P. Singh et al. (2021) "A formal testing model for operating room control system using internet of things," Computers, Materials & Continua, vol. 66, no.3, pp. 2997-3011. https://doi.org/10.32604/cmc.2021.014090

[14] Guangzhi, W., Mingna, L., Hongjun, W., Shan, Y., Zhenfeng, J., & Jiahang, S., et al. (2016). "Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells Via the Akt/Mtor Signaling Pathway", Journal of Cancer, 7(11), pp.1431-1440. https://doi.org/10.7150/jca.15497

[15] Nitta, Y., Shimizu, S., Shishido-Hara, Y., Suzuki, K., Shiokawa, Y., & Nagane, M. (2016). "Nimotuzumab Enhances Temozolomide‐Induced Growth Suppression of Glioma Cells Expressing Mutant Egfr in Vivo", Cancer Medicine, 5(3), pp.486-499. https://doi.org/10.1002/cam4.614

[16] Lu, T., Bao, Z., Wang, Y., Yang, L., & Cui, G. (2016). "Karyopherinβ1 Regulates Proliferation of Human Glioma Cells Via Wnt/β-Catenin Pathway", Biochemical & Biophysical Research Communications, 478(3), pp.1189-1197. https://doi.org/10.1016/j.bbrc.2016.08.093